Cardiovascular Therapy
GETROSE-F
Rosuvastatin 10mg + Fenofibrate 160mg
Dosage Form
Tablets
Packing
10x10 ALU
MRP
₹1600
Prescribed By
Cardiologist, Neurologist, Vascular Surgeon, General Physician, Internal Medicine
Quick Facts
Form
Tablets
Pack
10x10 ALU
MRP
Rs.1600
Prescribed By
Cardiologist, Neurologist, Vascular Surgeon, General Physician
Key Benefits
01
Targets both LDL and triglycerides simultaneously.
02
Useful for patients with mixed lipid abnormalities.
03
Reduces cardiovascular risk from multiple lipid fractions.
04
Convenient single tablet instead of two separate medicines.
Mechanism of Action
Rosuvastatin inhibits HMG-CoA reductase to reduce LDL cholesterol. Fenofibrate activates PPAR-alpha receptors to reduce triglycerides and raise HDL cholesterol. Together they provide comprehensive lipid management — lowering both LDL and triglycerides.
Indications
Mixed dyslipidaemia with elevated LDL and triglycerides, metabolic syndrome.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why GETROSE-F?
GETROSE-F addresses the full lipid picture — reducing LDL with Rosuvastatin and tackling high triglycerides with Fenofibrate in one tablet for comprehensive cardiovascular risk reduction.
